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Abstract
Non-thermal plasma technology is one of those techniques that suffer relatively little
from diffusion limits, slow kinetics, and complex geometries compared to more tradition‐
al liquid-based chemical surface modification techniques. Combined with a lack of sol‐
vents, preservation of the bulk properties, and fast treatment times; it is a well-liked
technique for the treatment of materials for biomedical applications. In this book chapter,
a review will be given on what the scientific community determined to be essential to ob‐
tain appropriate scaffolds for tissue engineering and how plasma scientists have used
non-thermal plasma technology to accomplish this. A distinction will be made depending
on the scaffold fabrication technique, as each technique has its own set of specific prob‐
lems that need to be tackled. Fabrication techniques will include traditional fabrication
methods, rapid prototyping, and electrospinning. As for the different plasma techniques,
both plasma activation and grafting/polymerization will be included in the review and
linked to the in-vitro/in-vivo response to these treatments. The literature review itself is
preceded by a more general overview on cell communication, giving useful insights on
how surface modification strategies should be developed.
Keywords: Non-thermal plasma technology, surface modification, tissue engineering,
scaffold fabrication, biomaterials
1. Introduction
In the 1980’s, researchers started first experimenting with the idea of fabricating human tissues.
But the true start of the field of tissue engineering was not until 1993, when Langer and Vacanti
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wrote their legendary paper. The philosophy behind tissue engineering, as published by its
two founders, is the following: “the loss of failure of an organ or tissue is one of the most frequent,
devastating and costly problems in human healthcare. A new field, tissue engineering, applies the
principles of biology and engineering to the development of functional substitutes for damaged tissue.”
In the two decades that followed, this new field in science expanded rapidly and continues to
do so up to this day. As scientists started to unravel the pathways that drive tissue regeneration,
it became clear that the fabrication of fully functioning human tissues was far more complex
than initially anticipated [1, 2]. Building a tissue from the bottom up requires a profound
knowledge of physics, chemistry, biology, and engineering and this from the macroscale (mm–
cm) down to the molecular level (Å). Steady progress has been made over the last 25 years,
resulting in some (commercial) successes such as Matrigel® and Dermagraft®. Alongside the
rise of the field of tissue engineering, non-thermal plasma technology has gained importance
as a cheap and efficient tool for the non-destructive modification of biomaterial surfaces. In
this book chapter, an overview will be given on how plasma technology has contributed to the
fabrication of better scaffolds for tissue engineering, preceded by an analysis on how to mimic
the human body best, down to the molecular level.
Figure 1. Different types of tissues available in the human body [132].
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2. Cellular communication
2.1. Tissue deconstruction
Before understanding that how cells can be manipulated to grow into the required type of
tissue, it is important to comprehend what a tissue exactly consists of. In general, a tissue is
composed out of (1) a certain set of cells (osteoblast, fibroblast, epithelial cell, neuroblast,
astrocyte...) from the same origin, forming the “building blocks” of a tissue, (2) an extracellular
matrix (ECM), forming the “cement” of such tissue, offering a 3D structural and biochemical
support, and (3) in most cases, a vascular network that allows transport of oxygen and nutrients
[3–5]. Depending on the type of tissue (nervous, muscular, epithelial, or connective tissue),
both the cell-types, cell ratio, and cell density, as well as the type of matrix (types of proteins
and their 3D configuration) will greatly vary, as shown in Figure 1. The key to a viable tissue
lies in its communication pathways: How do cells sense their environment? How do cells
communicate with each other? What is triggering the different steps in a cell’s life cycle? To
postulate an answer to these questions, one has to go down to the (sub)cellular level.
Figure 2. Schematic representation of cellular composition: (1) nucleolus, (2) nucleus, (3) ribosomes, (4) vesicle, (5) en‐
doplasmic reticulum, (6) Golgi apparatus, (7) cytoskeleton, (8) smooth endoplasmic reticulum, (9) mitochondria, (10)
peroxisome, (11) cytoplasm, (12) lysosome, (13) centrioles (open source).
2.2. Cell deconstruction
In basic biology, it is taught that a cell consists of a nucleus, containing the genetic information,
a number of organelles that are responsible for the cells metabolism, and a cell membrane that
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separates and protects the cell interior from its environment (Figure 2) [1, 2, 4–7]. A cell
constantly communicates with its environment and with other cells through signals released
by these cells. Cell signaling occurs through the cell membrane via transmembrane proteins
such as G-protein-coupled receptors and ion exchange channels or via diffusion of lipid soluble
molecules and small molecules (Figure 3). Part of the transmembrane proteins consists out of
a receptor site at the extracellular side of the membrane. When the matching signal molecule
(a protein, a peptide, or an amino acid) binds with such a specific available receptor site, it will
trigger a cascade of intracellular physico-chemical pathways that control the behavior of the
cell to a large extent.
Figure 3. Schematic representation of cellular membrane, depicting different types of transmembrane proteins (open
source).
2.2.1. What is ECM?
ECM is a protein-based support structure for cells, produced by cells. Initially, it was believed
that it was relatively inert, but today it is known to interact intensely and specifically with cells.
The main component categories of ECM are collagens (structural strength), elastin, proteo‐
glycans (matrix resilience), and glycoproteins (cohesive bonding). These are quite general
denominations for groups of proteins that show a surprisingly wide range of varieties, as it
has been discovered in the past decade [8, 9]. Structure-wise, ECM is as varied as it is chemically
diverse. In general, it could be described as a nanofiber matrix, mainly composed of collagen
fibers, consisting of bundles of collagen fibrils that are anchored to the basement membrane,
a dense sheet of collagen, lamilin, and other glycoproteins. How cells exactly interact with the
ECM and how critical that interaction is, will be discussed next.
2.2.2. Cell–ECM communication
Cells sensing their environment will mostly limit themselves to contact-dependent commu‐
nication pathways [8, 10, 11]. The main group of transmembrane proteins responsible for
sensing and communicating with the ECM is the integrin family. Integrins are transmembrane
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glycoproteins consisting of α and β subunits with a large extracellular receptor domain that
binds to certain RGD peptide sequences within the proteins (collagen, fibronectin, vitronec‐
tin...) that form up the ECM (see Figure 4). Up to this day about 20 different integrin trans‐
membrane proteins have been discovered, each responding to different RGD peptide
sequences. When an integrin binds onto the ECM, it will trigger the binding sites of the
cytoplasmic tail, resulting in the formation of focal adhesion structures. These focal adhesions
will bind to the cytoskeleton, triggering a cascade of intracellular signaling that will cause
changes in the gene expression, which in turn affects all aspects of cellular behavior such as
proliferation, differentiation, protein secretion, growth factor generation, and the generation
of survival signals that prevent the cell to go into apoptosis. What makes cellular signaling
(and communication) truly complex is that these transmembrane receptors rarely act alone:
Most communication pathways consist out of multicomponent systems that depend on both
the fixation of ligands on specific receptors as well as the transport of ions (e.g., Ca2+) via ion
channels [12]. Therefore, the key for designing a successful artificial matrix for the growth of
a tissue is to simultaneously take into account multiple types of signaling molecules (immo‐
bilized on such artificial matrix), as well as their 3D distribution and density. In what follows
next, an overview is given on how to design such 3D constructs.
2.3. Artificial ECM
The general idea behind tissue engineering is a three-step process (Figure 5): In the first step,
healthy cells are extracted and isolated from the patient involved; In the second step, these
cells are incubated in-vitro (in so-called bioreactors) on an artificial 3D construct that mimics
the natural ECM [3–5, 13]; In the third step, after the formed tissue has reached a certain degree
of maturation, the 3D construct is being implanted into the patient to replace the failing tissue
Figure 4. Schematic representation of integrin and cadherin activity [133].
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or organ. The material scientist within the group of tissue engineers is mainly interested in the
artificial 3D construct used during the second step and how to optimize it in such a way that
the seeded cells sense no difference compared to their natural support (ECM).
Figure 5. Schematic representation of the typical tissue engineering pathway followed [134].
2.4. Bio vs. artificial
The first step in fabricating appropriate cell support structures is the choice of material. As
the support is implanted in-vivo and a second surgery has to be avoided, it is essential that
the material is both biocompatible (preferably bioactive) and biodegradable [14–22]. This
first  condition  is  very  generic,  yet  it  rules  out  about  99  %  of  all  materials  available.
Considering the remainder of the materials available, three different fabrication strategies
can be followed: either work with a biopolymer that  is  sourced from a living organism
(e.g.,  collagen from pigs),  work with a synthetic  material  (e.g.,  polyesters  or  degradable
metal alloys), or work with sheets of living cells as such. Each strategy has its advantag‐
es and disadvantages. Biopolymers such as collagen, gelatin, fibronectin... are all found in
native tissue. Therefore, when cells are seeded onto such scaffolds, they do not lose their
enzymatic activity to interact with and modify the surrounding ECM-like structure to their
liking. The main downside using biopolymers is that they are extracted from foreign tissue,
causing  significant  variability  in  quality  as  well  as  a  constant  risk  for  the  transfer  of
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xenographic pathogens. From a mechanical point of view, most biopolymers do not have
the  structural  strength  to  be  used in  any load-bearing  applications,  limiting  themselves
mostly to “soft” tissue applications. Most properties of synthetic materials are complemen‐
tary to biopolymers, with their advantages pointing toward reproducibility, availability and
price,  degradation rate control,  and mechanical strength. Their most critical  downside is
that  their  surface  chemistry  does  not  resemble  the  natural  ECM  at  all.  The  interaction
between  the  cells  and  their  immediate  environment  will  therefore  be  very  different
compared  to  their  response  to  native  ECM,  thus  preventing  good  communication  be‐
tween  the  cells  and  their  surroundings,  resulting  in  sub-optimal  tissue  generation.  Cell
sheets  are  a  scaffold-free  alternative  but  are  quite  difficult  to  grow and handling  them
without damaging the delicate sheet is not without challenge [18]. In all cases, there are
solutions to the previously stated problems, some of them will be discussed further along
in the chapter, and others fall outside of the scope of the chapter but are discussed in other
excellent review papers [18, 20, 23–26].
2.5. (Bio)scaffold fabrication
Independent of the chosen material (living or dead), it still needs to be processed into a suitable
3D structure, resembling a natural extracellular environment. In the early days of in-vitro
culturing, cells were seeded onto flat sheets and their response was studied. As scientists
started to unravel the communication mechanisms of cells, it was concluded that 2D surfaces
were bad models for cell studies, as cell morphology and behavior are greatly influenced by
what it senses on all sides (see Figure 6). Alongside other developments in tissue engineering,
material scientists and engineers therefore started developing techniques that would allow
them to grow cell cultures in-vitro in a 3D environment [1, 27–29]. This research partially
resulted in a new field within the tissue engineering community that is now known as
biofabrication. In what follows, the most commonly used scaffold fabrication techniques will
be discussed in more detail, followed by how non-thermal plasma technology can add value
to the performance of such fabricated structures.
2.5.1. Conventional fabrication methods
Conventional methods for manufacturing scaffolds include solvent casting and particulate
leaching, gas foaming, fiber meshes and fiber bonding, phase separation, melt molding,
emulsion freeze drying, solution casting, and freeze drying [30].The repetitive limitations of
this family of techniques is that they are all inherently limited when it comes to pore size
control, pore geometry, pore interconnectivity, and the possibility to construct internal
channels for transportation of oxygen and nutrients (see Figure 7). The limited poor intercon‐
nectivity prevents good cell migration, resulting in a high density of cells near the scaffold
surface, with very little cells at the center.
Traditional scaffold fabrication methods were made very popular in the early days of tissue
engineering, as the use of leaching salts, porogens, and supercritical fluids were cheap
fabrication methods that did not require specific and/or expensive machinery [25]. To over‐
come the problem of poor pore interconnectivity, researchers at that time strived to develop
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scaffolds with high pore ratios, up to 90 %. Although this partially resolved the pore inter‐
connectivity problem, it resulted in scaffolds with mediocre to poor mechanical properties [31].
A special case of a conventional scaffold fabrication method is the supercritical fluid process‐
ing. As it is a solvent-free technique, it is better suited than the other methods mentioned.
Supercritical fluid (SCF) is created once a substance is exposed to an environment where its
critical temperature and pressure are exceeded [32, 33]. A further increase in compression will
therefore no longer result in liquefaction. Its physical properties are a combination of both
liquid properties (density and solubility) and gas properties (diffusivity and viscosity). The
most commonly used SCF is CO2, as it is cheap, readily available, and reaches its supercritical
point at near-room temperature (31°C, 7380 kPa). One of the more interesting properties of
SCF’s is their ability to dissolve polymers at a much lower temperature than their normal Tg.
Making use of this property, Mooney et al. [6] were one of the first groups to apply this
technique for the fabrication of microporous scaffolds. They dissolved a poly (lactic-co-
glycolic) acid (PLGA) disc in CO2 under SCF conditions. By rapidly decreasing the pressure,
the solubility of the CO2 decreases, causing nucleation and growth of gas bubbles within the
polymer disc. The result is a sponge-like structure consisting of a high density of pores with
varying size. The fact that no solvents were needed made it an excellent technique for tissue
engineering applications. Several groups picked up on the technique, and it is still used to this
day. Despite the lack of solvents during the production process, it suffers from the same
limitations as the other conventional techniques though, inherently limiting it as a viable
option for tissue engineering.
Figure 6. Differences in cell attachment efficiency between microporous and microfiber scaffolds on the one hand and
nanofiber scaffolds on the other hand [135].
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Figure 7. Micro-CT scan of traditionally fabricated scaffold via solvent casting/particulate leaching (A). B and C are
showing the porous interconnectivity and pore size, respectively [136].
2.5.2. Rapid prototyping
Rapid prototyping is the collection of fabrication techniques that are able to directly translate
a computer-generated design into a physical model. They are considered to be an additive
process in which all parts of the construct are grown in a layer-by-layer fashion [20, 30, 34,
35]. The family of rapid prototyping techniques can be subdivided into two categories,
depending on their mode of assembly: melt/dissolution deposition and particle bonding.
A melt/dissolution deposition system for tissue engineering applications can be considered as
a miniature version of the traditional extrusion systems used in thermoplastic polymer
processing, combined with an XYZ moving platform. The polymer, either molten or dissolved,
gets forced through a small nozzle, after which it solidifies on the moving platform. Depending
on nozzle size, temperature/concentration, and moving speed, a wide range of filament
thicknesses can be extruded. Based on the digital design, a repetitive pattern can be printed,
producing a porous structure with well-defined, well-interconnected pores in all directions,
as can be seen in Figure 8. The typical pore size ranges typically from 100–1000 µm. More
recently, the focus has shifted from thermoplastic biodegradable polymers to hydrogels, as
several research groups have now succeeded to mix cells within the polymer feed [36, 37]. This
generates hybrid scaffolds that are composed of both dead and living species.
Particle bonding systems use particles that are selectively bonded in a thin layer of powder
material. These thin layers are then bonded onto each other in complex 3D structures, while
being supported by unbounded material. At the end, the unreacted powder is removed and a
well-defined interporous structure is obtained that exhibits both macropores and micropores
(depending on the particle size of the powders). As the material is bonded via laser light or
via adhesive droplets, dispersed via an inkjet type system, the amount of suitable polymers is
limited.
While well-defined, geometrically complex 3D structures with excellent pore interconnectivity
can be fabricated, they still exhibit a pore size that is an order of magnitude higher than what
is found for natural ECM. This is not the case for that other popular scaffold fabrication
technique: electrospinning.
Non-thermal Plasma Technology for the Improvement of Scaffolds for Tissue Engineering and Regenerative...
http://dx.doi.org/10.5772/62007
209
Figure 8. Top (A) and side (B) view of scaffold fabricated via microextrusion system [137].
2.5.3. Electrospinning
Electrospinning (ES) of polymers was already patented for the first time in 1939, but it was not
until the early 1990 that a renewed interest in the 1D scaffold fabrication technique made it
into the popular tool that it is today [38–43]. A typical ES machine consists of three major parts
(see Figure 9): 1) a needle pump, feeding a polymer solution, at a certain flow, into the ES
spinning chamber; 2) a high voltage source that is connected to the needle; 3) a grounded
collector plate at a distance x from the needle. When applying a sufficiently high potential
difference between the needle and the collector plate, the surface tension of the polymer droplet
will break, resulting in the formation of a jet of polymer solution toward the collector plate.
As the polymer solution travels at a high speed, the solvent will start to evaporate, resulting
in the generation of nm-thick fibers that are then forming a randomly ordered 2D fiber sheet
onto the collector plate (see Figure 9). The main difference between the ES and the other
discussed scaffold fabrication techniques is the dimension range. As the fibers have a thickness
in the order of nm, they are able to form µm- and nm-size pores, closely resembling the
structures found in natural ECM. In the past 20–25 years, a wide variety of different polymers
have been successfully electrospun, including most biodegradable and natural polymers. The
biggest downsides of the ES technique are its lack in structural strength, thus preventing its
use in load-bearing implant applications, and due to its dense packing, it makes it difficult for
cells to migrate deeper into the spun matrix.
3. The added value of non-thermal plasma technology
As mentioned earlier, synthetic biodegradable polymers have a number of advantages
(reproducibility, price...) and disadvantages over biopolymers and cell sheets [18]. Their main
disadvantage is their lack of proper surface properties that stimulate the adhesion and
proliferation of cells and differentiate them into the right type of tissue [44]. Numerous wet-
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chemical techniques have been developed and applied, but most of them are either too
aggressive, (partially) destroying the delicate structures, showing low treatment efficiency,
time-consuming, or waste generating...
Non-thermal plasma technology is known as an excellent tool for surface engineering and a
valid alternative for wet-chemistry-based surface engineering [14, 15, 45, 46]. It has been
extensively used for surface decontamination/etching and surface treatment/activation on the
one hand and the grafting/deposition of thin films with unique properties on the other hand.
Its lack of solvents, fast treatment times, and preservation of bulk properties make it an ideal
treatment method for delicate tissue engineered constructs [47]. Originally, research was
focused on low-pressure plasma systems as they are well defined; exhibit excellent plasma
stability; obtain good treatment efficiencies; and are able to deposit dense films that adhere
well, are pinhole free, and show excellent stability. In the past two decades, there has been a
shift toward research at (sub) atmospheric pressure as it eliminates the cost of extensive
vacuum equipment and is less time-consuming, albeit not as well defined, and deposit films
that are less dense.
In the following part of the chapter, an overview will be given on how both low-pressure and
atmospheric pressure plasma technology have improved the performance of scaffolds for
tissue engineering produced with different fabrication strategies.
3.1. Non-thermal plasma activation
Exposing a substrate to a plasma discharge fueled by an inert gas is the more basic approach
for increasing the surface energy of said surface [14, 15, 48, 49]. Depending on the type of inert
gas used, functional groups will be introduced directly (O2, CO2, air), indirectly (He, Ar) via
post-oxidation processes, or a combination of both (N2, NH3, CF4). At the same time, most
plasma treatments will induce some degree of roughness, also contributing to the increase in
wettability and surface energy, as has been extensively studied in the past on flat surfaces (see
Figure 10). When applying a plasma treatment onto a scaffold structure, it is important to take
Figure 9. SEM micrograph of PCL electrospun fiber mesh (left: open source; right: original).
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the time-dependent character of the treatment into account. The gradual decrease in treatment
efficiency upon storage, also known as the aging effect, is something that is often overlooked
in literature. The substrate surface will try to return to a more stable energy state by lowering
its surface energy again. This is either accomplished via polymer chain reorientation or the
desorption of low molecular weight components. Depending on the substrate characteristics
(crystallinity, molecular weight, storage atmosphere), they will lose up to 90 % in treatment
efficiency over a period of only weeks. Using proper storing conditions (vacuum, low tem‐
perature) can slow down the ageing effect significantly, though it is something that has to be
kept in mind when developing scaffolds for tissue engineering applications.
Figure 10. The change in WCA after 5 min of air plasma treatment at atmospheric pressure [129].
In the overview of the literature, it is clear that the developed non-thermal plasma surface
modification strategies were in their early stages. As the scaffold fabrication methods evolved,
plasma technological solutions also became more in tune with their microbiological environ‐
ment. This specific chapter section therefore consists mainly out of basic surface-cell interac‐
tions, with the more advanced modification strategies following thereafter [138].
3.1.1. Traditional fabrication methods
To our best knowledge, it was not until 2002 that the first articles were published on the
treatment of traditionally produced scaffolds with non-thermal plasma. Chim et al. [50] used
a vibrating salt leaching method to fabricate poly(D,L) lactic acid (PDLLA) scaffolds, after
which they applied an oxygen low-pressure radio frequent (RF) plasma (100 W–3 min). Static
water contact angle goniometry (WCA) measurements showed a decrease in contact angle
from 80° down to 60°, indicating an increase in surface polar groups, yet no X-ray photoelectron
spectroscopy (XPS) or secondary ion mass spectrometry (SIMS) was performed to quantify
this. Scanning electron microscopy (SEM) measurements revealed an increase in surface
roughness as well as the formation of sub-µm-sized pits. The seeding of embryonic palatal
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mesenchyme (HEPM) cells into the scaffold resulted in a five-fold increase in cell activity
compared to untreated scaffolds, while measurements of alkaline phosphatase activity (ALP)
indicated an accelerated cellular differentiation into osteoblasts. Köse et al. [51] followed a
similar strategy for the fabrication and treatment of poly(3-hydroxybutyrate-co-3hydroxyval‐
erate) (PHVB) scaffolds and their subsequent seeding with osteoblasts.
Around the same time, Claase et al. [52] used both freeze drying and salt leaching to synthesize
scaffolds from different poly(ethylene oxide terephthalate)/poly(butylene terephthalate)
(PEOT/PBT) mixtures, a copolymer that supposedly would enhance osseointegration. First lab
tests revealed no significant increase in osseointegration, independent of composition. A
CO2 RF low-pressure plasma (49 W–30 min) was applied, but no surface characterization
techniques were used to analyze its effects. Goat bone marrow cells were seeded into the
scaffolds, after which a whole range of in-vitro tests revealed that the plasma treatment had a
positive effect on adhesion and proliferation, but only for certain copolymer compositions
(PEOT/PBT in ratio 70/30), while pore size was only of minor influence. A few years later, the
experiment was repeated with rat bone narrow stromal cells, giving very similar results for
the growth of cartilage rather than bone [31].
It is now considered to be general knowledge that surfaces rich in primary amines are excellent
for the initial adsorption of certain proteins, thus positively stimulating cell behavior. Yang et
al. [53] were, to our knowledge, the first to use an ammonia low-pressure RF plasma (50 W–5
min) on traditionally fabricated scaffolds (solvent casting + salt leaching specifically). WCA
measurements on the plasma-treated poly-L-lactic acid (PLLA) and PLGA scaffolds indicated
a high increase in wettability (78° →  15°), while XPS showed the incorporation of 4–6 % of
nitrogen. Human foreskin fibroblasts were seeded, resulting in a significant increase in cell
viability according to the performed MTT assays. Fluorescence microscopy showed an
elongated morphology and a distinctively higher seeding efficiency.
Choi et al. [54] focused on the surface alteration of commercially available calcium phosphate
scaffolds (200–400 µm pore size) using an atmospheric pressure plasma jet (APPJ) with either
air or nitrogen as a discharge gas (15 kV, 13 mA, 5 slm, 10–20 min). WCA were reduced from
80° to <10°. XPS analysis revealed that the relatively high hydrophobicity was caused by
significant carbon surface contamination, which was sharply reduced by the plasma treatment
in favor of the introduction of –OH groups onto the surface. MC3T3 mouse osteoblasts were
seeded on scaffolds treated with either air or nitrogen. Adhesion assays revealed a significant
increase in cell adhesion compared to untreated scaffolds, even though no differences were
found between treatments. Proliferation analysis revealed though that cells seeded onto
nitrogen-treated surfaces proliferated at a higher rate, which can be linked back to the influence
of amine rich surfaces. Morphology analysis learned that cells were still quite round, suggest‐
ing that the activation step as such is insufficient. This indicates that a grafting step or coating
step might be better for initial cell-surface interactions, while still benefiting from the long-
term effects of the underlying CaP substrate.
In the following 13 years, several other research groups have performed comparable plasma
surface treatments on scaffolds produced via conventional fabrication methods. Their results
have been summarized in Table 1. Most found significantly better cell adhesion and good cell
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proliferation. Ring et al. [55] also proved that a plasma treatment can lead to better neovascu‐
larization, while Shah et al. [56] showed that the results obtained in-vitro do not always
translate well in-vivo, bringing a whole new set of challenges.
Author year scaffold type fabrication method reactor& gas cell-type effect
Safinia et al. [57] 2005 PDLLA thermally induced phaseseparation
low pressure RF
air &NH3
/ higherwettability
Wan et al. [58] 2005 PLLA phase separation low pressure RFNH3
M3T3
fibroblasts
better cell
proliferation
Safinia et al. [59] 2007 PS/PLGA thermally induced phaseseparation APPJ /
higher
wettability
Ring et al. [55] 2010 Matriderm® commercial low pressure RFAr/H2
in-vivo
better
neovascularizati
on
Han et al. [60] 2011 PLA-PCL solvent casting/ saltleaching
atmospheric
pressure bipolar
DC
L929 & MC3T3
osteoblasts
no cytotoxicity &
homogeneous
distribution
through scaffold
Shah et al. [56] 2014 PLA vibrating particle/ saltleaching
low pressure RF
O2
osteoblast &
endothelial co-
culture
in-vitro
synergetic
in-vivo location
dependent
Bak et al. [61] 2014 PCL gas foaming/ saltleaching
low pressure RF O2
& N2
MC3T3
osteoblasts
enhanced
adhesion and
proliferation
Sardella et al. [62] 2015 PCL solvent casting/ saltleaching
low pressure RF
H2O/N2
Saos-2
osteoblasts
50/50 H2O/N2
best cell
adhesion and
proliferation
Trizio et al.
[63] 2015 PCL
solvent casting/ salt
leaching APPJ He/O2
Saos-2
osteoblasts
cell-clustering,
polymorphal
shape slow
spread
throughout
scaffold
Table 1. Overview of literature on plasma modification of traditionally fabricated scaffolds not discussed in the text.
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3.1.2. Rapid prototyping
Rapid prototyping techniques were introduced to the tissue engineering community in the
late 1990s [64–66]. Still, it took almost a decade before the first papers were published that
involved plasma treatment of such structures, with the majority of the papers published in the
past 5 years. The first paper, to our knowledge, was published by Wagner et al. in 2006 [67].
They developed an in-house system and printed PLGA scaffolds with 1.3 mm (!) gaps, after
which they treated them with an oxygen low-pressure RF plasma (0.04 kPa, 5 min, 15 kV). No
surface analysis was performed. Ovine and human osteoblasts were seeded, and results were
compared to untreated scaffolds and tissue foil. Improvements in cell adhesion and prolifer‐
ation were found compared to the untreated scaffolds, but results were worse compared to
the tissue foil. In theory, one can still talk about a 3D scaffold in this case but with such pore
sizes results will always be similar to what is found for cell-seeding on 2D films, as the gaps
will be too big for cells to bridge.
In 2007, Moroni et al. [68] applied an Ar low-pressure RF plasma treatment (0.01 kPa, 30 min)
on PEOT/PBT scaffolds printed on an Envisiontec® system. Both scaffolds based on generic
designs as well as those based on CT scans from actual patients were used in this study. Again
no surface analysis was performed. A SEM study of the scaffolds revealed a significantly higher
degree of printing imperfections for the patient-based scaffolds. Yet, when in-vitro tests (MTT
+ GAG) were performed, the patient-based scaffolds performed remarkably better in terms of
tissue formation and differentiation compared to the generic ones, both being treated with the
non-thermal plasma. This indicates that biomimetic scaffold designs also play an important
role for successful tissue engineered constructs.
Yildirim et al. published two papers on the modification of polycaprolactone (PCL) scaffolds
with pore size 300 µm, printed using an in-house system [69, 70]. In both cases, an O2 low-
pressure RF plasma (18 W, 0–7 min) was applied. WCA measurements showed a progressive
increase in wettability (58° →  22°). XPS measurements revealed an initial increase in oxygen
functional group incorporation (up to 1 min treatment). Further treatment resulted in a
decrease to values similar to untreated PCL. This suggests that the main effect of the oxygen
plasma is etching rather than functional group incorporation. 7F2 mouse osteoblasts were
seeded in both cases, giving similar results: enhanced adhesion and differentiation (higher
levels of ALP and osteocalcin), and accelerated formation of mixed mineralization, all indica‐
tions of increased osseointegrating properties. In 2012, Jacobs et al. [71] performed a more
systematic study of different plasma discharge gasses (Ar, He and air) on PCL printed
scaffolds, using a medium pressure parallel-plate system (5 kPa, 1–2 W, 30–300 s). Short
treatment times resulted in the formation of a wettability gradient toward the center of the
scaffold, as visualized by a standardized ink-staining method [72]. Longer treatment times
resulted in a homogeneous wettability throughout the scaffolds, as confirmed by XPS (%O +
7 %). MC3T3 osteoblasts were seeded into the scaffold. Initial cell adhesion, as well as cell
proliferation, greatly increased for those scaffolds treated by plasma, covering the complete
interior of the scaffold (see Figure 11). Cell morphology was more elongated, and protein levels
were higher.
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Figure 11. Fluorescent micrographs of PCL scaffold cross-sections of MC3T3 seeded osteoblasts. Left, from top to bot‐
tom (a–e): untreated scaffolds after 1–3–7–21 days of seeding. Right, from top to bottom (b–h): air plasma-treated scaf‐
folds after 1–3–21 days of seeding [137].
3.1.3. Electrospinning
To this day, electrospun or e-spun fibers are considered to be the closest (semi)synthetic
alternative to natural ECM, being one of the only techniques that is able to reproducibly
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fabricate scaffolds with sub-µm features on a larger, economically viable scale. As already
mentioned, it is a relatively old technique (1939) that only gained renewed interest two decades
ago, it was not until 2005 that the first papers were written on the plasma modification of such
fibers.
Baker et al. [73] were one of the first groups searching for a non-invasive method to improve
the cell attachment of finite smooth muscle cells on both randomly and aligned polystyrene
(PS) fibers. An Ar RF plasma was applied (296 W, 0.01 kPa) for 5 min, and surface analysis was
performed. The speed of adsorption of water was so high that it was impossible to measure
correct WCA, while XPS measurements revealed a 20 % increase of oxygen, which is similar
to results found for 2D films [74]. Cell attachments assays indicated a twofold increase in
adhesion and actin staining images show that the cells align very well along the direction of
the fibers. Despite the excellent in-vitro results, serious questions have to be raised to the use
of PS as a modern implant material, as it is not biodegradable.
Figure 12. Improved cell infiltration into electrospun scaffolds after plasma treatment (left) and improved cell mor‐
phology (right) Jeon et al. [139].
Synthetic biodegradable polyesters such as PLA and PCL were often the material of choice for
the fabrication of traditional and rapid prototyped scaffolds, and this is no different for the
fabrication of electrospun materials. Several publications were published in the last 7 years
where either PCL or PLA nanofibers were exposed to a plasma treatment [75–84]. Both low-
pressure RF systems and atmospheric pressure plasma jets (APPJs) were used to generate
plasma discharges using a variety of discharge gasses (air, NH3, Ar, N2 + H2, O2, or a combi‐
nation of those). As was the case for the other fabrication techniques, several publications lack
proper surface analysis, hence introducing a novel surface modification technique, but not
characterizing what changes are taking place and to what extent. Those papers that did include
a (partial) material analysis found the following results: WCA for PLGA fibers were decreased
from 135° to around 45° in most cases. For PCL and PLLA, most were able to achieve full
adsorption of the droplet (WCA =0°). XPS measurements showed an increase in oxygen
containing functional groups between 2 and 7 % for PL(G)A, pure O2 plasma treatment being
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the only one to achieve an increase of more than 4 %. The oxygen content of PCL fibers was
increased up to 12 %. Those papers that used N2 or NH3 were able to incorporate up to 5 % in
nitrogen containing groups, but no additional derivatization of alternative techniques were
used to see what type of nitrogen groups were incorporated onto the surface. The changes in
surface wettability came at a cost though. Tensile tests revealed a reduction between 30 and
40 % in tensile strength, indicating that plasma no longer can be viewed as a non-invasive
technique when it comes to scaffolds with sub-µm dimensions. Whereas the papers in most
cases lack proper surface characterization, they excel in providing good quality in-vitro and
in-vivo results. Almost all studies revealed an increase in initial adhesion and cell morphology
and this for practically any cell-type tested (fibroblasts, osteoblasts, smooth muscle cells, stem
cells, Schwann cells...), but some studies went into even more detail. Park et al. [78] studied
the adsorption of Bcl-2 proteins as a function of incorporated N-density on their e-spun PLGA
scaffolds. Results showed that a mediocre hydrophilicity (WCA between 50° and 60°) resulted
in the highest uptake of said protein. In parallel, they seeded fibroblasts onto the ammonia-
treated scaffolds and found that the protein expression of the cells followed the same trend,
with an overall reduction in the expression of stress-induced reactive oxygen species (ROS)
secretion. De Valence et al. [79] tested their air plasma-activated PCL vascular grafts in-vivo,
even after disappointing results in-vitro. Whereas the smooth muscle cells showed no
significant increase in proliferation in-vitro, in-vivo tests revealed that cells were able to
penetrate the scaffolds more efficiently and at higher densities, mainly due to the increased
wettability. Cheng et al. [85] found similar results in-vivo for their Ar-/NH3-treated PLA
scaffolds – indicating that for cell infiltration, wettability is most likely the critical factor. When
it comes to mineralization, Yang et al. [76] found similar results compared to Yildirim et al. [86]
in the rapid prototyping section: improved mineralization within the first few hours after
immersion of Ar plasma-treated scaffolds into simulated body fluid (SBF) solution. This
resulted in the complete filling of the (sub)µm pores within 6 hours. After 7 days, the CaP was
converted into type B carbonate apatite, the same building block found in natural apatite. Still,
due the inferior properties of e-spun fibers compared to printed structures, it is to our belief
that e-spun scaffolds as such will never be used for the repair of bone-related defects, unless
combined with a polymeric, metallic, or ceramic support structure.
Whereas most other scaffold fabrication techniques were limited to biodegradable polyesters,
electrospinning has a much broader spectrum of materials available. Biodegradable polyur‐
ethanes (PU) are a viable alternative to biodegradable polyesters, yet it is known that in some
cases they trigger a more aggressive immunological response upon implantation [87]. Zandén
et al. [88, 89] published two papers on the influence of O2 RF low-pressure plasma treatment
on the haemocompatibility of PU meshes and their influence on human embryonic stem cells.
In both papers, they had to conclude that a plasma treatment as such is insufficient to signif‐
icantly alter the haemocompatibility or to stimulate the differentiation of stem cells. Ardeshir‐
ylajimi et al. [90] exposed polyether sulfone scaffolds (PES) to an O2 low-pressure microwave
(MW) plasma (0.04 kPa, 10 min). In-vivo, studies with rabbits revealed that the scaffolds
induced an increase in ALP levels and a significant increase in calcium content was found. The
relative expressions of Runx2, Col 1, osteonectin, and osteocalcin analyzed via reverse
transferase–polymerase chain reaction (RT-PCR) were all elevated within the first week.
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Surprisingly, analysis of scaffolds implanted for more than 7 days showed that the expression
levels dropped drastically and no more significant differences were found compared to
untreated samples (which might be due to possible ageing effects of the plasma-treated
scaffolds).
Electrospinning is the only scaffold fabrication technique, to our knowledge, where plasma
has been successfully applied to improve the surface properties of biopolymers. In general,
biopolymers are frequently used to fabricate scaffolds via other scaffolding techniques (e.g.,
rapid prototyping), but due to their high water content, it is less obvious to apply a non-thermal
plasma, whereas electrospun materials are normally used in a dehydrated state. Baek et al.
used an MW induced Ar plasma jet to modify electrospun/salt leached silk fibroin scaffolds
(400 µm) intended for cartilage repair [91, 92]. Neonatal human knee articular chondrocytes
were seeded onto scaffolds, resulting in a 50 % increase of initial cell attachment and a 100 %
increase of proliferation compared to untreated scaffolds. Although, when the GAG content
was analyzed, little to no difference was found for the treated scaffolds, indicating yet again
that plasma treatment is not specific enough when it comes to the stimulation of secondary
processes such as the enzymatic excretion of polysaccharides.
3.1.4. Intermediate conclusion
The overall conclusion that can be made for plasma-treated scaffolds is that it greatly increases
the wettability of the scaffolds, allowing for a more efficient seeding process. This is reflected
in significantly higher cell adhesion within the first 24 hours and a better distribution of the
cells throughout the scaffold. After 7 days, though, the advantages of plasma treatments on
cell proliferation are in most cases less substantial. This is most probably due to the non-specific
nature of the introduced functional groups onto the surface of the scaffold interior. In the
introduction, it was mentioned that cell signaling is highly dependent on the type and
distribution density of transmembrane proteins protruding from the cell surface. Both the type
of substrate functional groups and their density thus play a major role in the metabolic
pathways of the cell. A more hydrophilic surface does allow cells to initially attach better, but
as the correct integrin bond is missing, proper cell proliferation, and differentiation are
inhibited. Nitrogen-rich surfaces perform better compared to oxygen rich surfaces, as in most
cases they will contain a certain amount of primary amines, which is one of those functional
groups preferred by cells for bone regeneration (or by the proteins initially excreted by the
cells or present in the growth medium). However, there is often no control of functional group
densities. Therefore, to better mimic the ECM environment, it would be recommended to have
a higher control over the type of functional groups on the surface and their distribution, which
are two parameters that can be better controlled by plasma grafting and plasma polymeriza‐
tion, which will be discussed next.
3.2. Plasma grafting and polymerization
Thin polymer-like films deposited via plasma polymerization are considered very different
from films deposited via traditional wet-chemical techniques in the sense that the monomer
gets fractionalized when exposed to plasma. This results in highly branched, highly cross-
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linked amorphous networks. These nm-thick films are often characterized as highly stable,
dense, extremely adhesive to the substrate, and pinhole free (although not all these character‐
istics transfer well from low-pressure systems to atmospheric pressure systems and are
influenced substantially by the set of plasma parameters used). As it is a solvent-free deposition
technique, it is considered an excellent tool for tissue engineering applications.
Plasma grafting is a hybrid technique positioning itself between plasma treatment and plasma
polymerization. The plasma step itself is identical to a plasma treatment, the (macro)monomer
being introduced only after plasma treatment. Either the introduced reactive sites are then
used directly as initiation points for free radical vinyl polymerization or afterwards by using
the introduced oxygen/nitrogen functional groups to covalently bond other (macro)molecules,
involving a wet-chemical step. This results in coatings with excellent retention of the functional
groups, but low surface functional group density control. Both techniques are considered
superior compared to plasma treatments when it comes to the variety of functional groups
that can be introduced onto a scaffold surface and their stability over time.
3.2.1. Traditional fabrication methods
One of the best-known papers on plasma grafting and plasma polymerization applied on
traditionally fabricated PDLLA scaffolds (supercritical CO2) was published in 2005 by Barry
et al. [93]. In this paper, an O2 low-pressure RF plasma was used (40 Pa, 3–20 W, 3 min) to
compare the penetration efficiency of allylamine when plasma grafted or plasma polymerized,
respectively. XPS cross-sectional analysis revealed that for the grafting an evenly distributed
nitrogen signal could be found, but at relatively low atomic concentrations (2 %) (see Figure
13). Plasma polymerized allylamine resulted in incorporation of up to 10 % nitrogen but after
washing a parabolic gradient was found. They linked this gradient to limitations in diffusion
of the allylamine precursor due to the limited pore interconnectivity. For the grafting step, as
they allow the monomer to flow through the scaffold for up to 10 min, they claim that it
eventually will penetrate all of the scaffold, but at a lower incorporation efficiency. In-vitro
tests, using M3T3 fibroblasts revealed that only for the plasma polymerized scaffolds the cells
were able to penetrate to the center of the scaffolds, while at the same time showing higher
densities a the scaffold surface. This indicates that a certain density of polar functional groups
is required to allow cells to effectively migrate throughout the scaffolds. Furthermore, it is an
important indication of the diffusion limitations of traditionally fabricated scaffolds: Allyla‐
mine is a very small molecule, yet sharp gradients in coating chemical composition could be
found. The diffusion limitations will increase exponentially when applying larger precursors
for polymerization or trying to immobilize larger biomacromolecules such as collagen, gelatin,
fibronectin...
Six years later, this research was picked up again by the same group in collaboration with the
University of Bari, resulting in the publication of two papers by Intranuovo et al. [94, 95]. In
the first paper, published in 2011, a very similar experiment was conducted involving low-
pressure RF pulsed plasma polymerization of allylamine, with very similar results when it
comes to gradient deposition. To improve the migration of the 3T3 fibroblasts used in the
experiment, a hexane plasma was applied for a very short time (30 s) directly after the
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allylamine plasma polymerization step. Hexane, being a bigger molecule, was limited even
more when trying to diffuse into the scaffold. Combined with the short treatment time, this
resulted in a hydrophobic outer surface of the scaffold. Upon seeding, the fibroblasts were
“forced” to migrate into the scaffold. 96 hours after seeding cross-sectional imaging revealed
a homogeneous distribution throughout the scaffold. In the paper published 3 years later, they
again repeated the experiment, but using C2H4/N2 mixture (3 min) instead, followed by a
hydrogen plasma (30 s) to introduce primary amines onto the surface. In a second step, they
solely used C2H4 plasma (90 s) to introduce reverse gradients (more nitrogen in the central part
of the scaffold). Having used even smaller molecules compared to allylamine paid off, as the
gradient throughout the scaffolds was far less pronounced, with up to 7 % of nitrogen
functional groups in the center of the scaffolds. This also showed in the in-vitro testing, with
Saos-2 osteoblasts evenly distributed for scaffolds both with and without the ethylene plasma
step, thus being an example of an over-engineered solution.
In two papers published by the biomaterials research center of South Korea, O2 low-pressure
RF plasma systems (30 s, 0.1 Pa) were used to activate PLLA scaffolds, followed by an acrylic
acid grafting step [96, 97]. Chondrocytes were seeded onto the scaffolds, and significant
increase in adhesion and proliferation was found. Four weeks after seeding, higher levels of
collagen II were measured as well as increased GAG levels, indicating the formation of
cartilage. The success of the in-vitro tests was related to the acid rich surface, as well as an
increase in surface roughness. Demirbilek et al. [98] focused their study on the changes in
oxidative stress caused by plasma grafting. They used the freeze drying technique to fabricate
their scaffolds. After plasma treatment (no details given), scaffolds were grafted with either
Figure 13. Distribution of nitrogen through traditionally fabricated scaffold: plasma grafting versus plasma polymeri‐
zation [140].
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ethylene diamine or low-molecular weight PEG. L929 osteoblasts were seeded, and oxidative
stress was measured both via malondialdehyde and advanced oxidation protein products.
Surprisingly, results showed that the level of oxidative stress was greatly reduced compared
to cells grown on untreated scaffolds, even for PEG-grafted scaffolds, which are normally
considered to be anti-fouling.
Several authors used low pressure plasma systems to activate PLGA scaffolds (O2/CO2, Ar and
NH3 plasma, respectively) fabricated via phase separation/ salt leaching in order to immobilize
a biomacromolecule of choice [99–101]. Hu et al. [101] immobilized both polylysine (enhances
electrostatic interactions) and RGD peptides, using a glutaraldehyde linker. Osteogenic
precursor cells were seeded onto the scaffolds and after 14 and 28 days, alkaline phosphatase
(ALP) activity and calcium assays were performed to determine the level of osteogenic
differentiation. Results showed that the introduction of charge (either via NH2 or polylysine)
was not enough to stimulate differentiation, whereas the introduction of RGD peptides
resulted in a significant increase in ALP activity and calcium concentration. This indicates that
the RGD-peptide activity is well preserved, resulting in a stimulated osteogenic differentiation
of the precursor cells. Woo et al. [100] immobilized β-glucans, a polysaccharide known for its
enhanced wound healing properties, onto their scaffolds. Adipose tissue-derived stem cells
were seeded onto the scaffolds, resulting in enhanced cell proliferation and improved cell
morphology (more spindle like). Unfortunately, no studies were performed on differentiation.
Shen et al. [99] immobilized rhBMP-2, an osteoinductive protein. Different plasma discharges
were tested, and those that introduced a negatively charged surface were found to be most
efficient in immobilizing the positively charged protein (O2 and CO2 vs. NH3). OCT1 osteo‐
blasts were seeded and ALP activity measurements indicated a significant increase, while SEM
images showed accelerated mineralization within 22 days. Zheng et al. [102] used a different
approach to obtain similar results, using a PLGA-tricalciumphosphate composite scaffold
(phase separation + particle leaching). After ammonia plasma treatment, the scaffolds were
dipped in a collagen solution, effectively immobilizing some of it onto the surface. Ex-vivo
analysis of seeded rat dental pulp stem cells indicated greatly enhanced ALP activity (20 times
higher), while von Koss staining showed increased areas of mineralization and Azan staining
showed the presence of dentin proteins, all of which are indications of dentin-like bone
formation.
Overall, quite a diverse group of traditional scaffold modifications has been discussed above.
Compared to the plasma treatment sections, results are far more promising when it comes to
cell proliferation, and especially cell differentiation. In-vitro, ex-vivo, and in-vivo experiments
have shown that plasma-modified traditional scaffolds could be successfully applied to grow
bone and cartilage tissue. Most papers though, avoid the topic of treatment homogeneity, while
the first few papers discussed in this section, as well as papers discussed in the plasma
treatment section, clearly show that this is an important issue to take into account. With this
gradient problem taken into account, it is no surprise that there are very few papers available
that focus on plasma polymerization of traditionally fabricated scaffolds or on the distribution
homogeneity of the larger immobilized biomolecules such as rhBMP-2, β-glucans, or collagen.
For both rapid prototyped structures, with their high pore interconnectivities, and electrospun
fibers, with their extremely high porosity, this should not be such an issue.
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3.2.2. Rapid prototyping
All papers found on plasma grafting and polymerization for rapid prototyped scaffolds were
published in the last 4 years, indicating a large potential for further studies. Between 2012 and
2014, several papers were published by Declerq et al. and Berneel et al., following the same
plasma grafting procedure [103–105]. PCL scaffolds (200 µm pore size) printed via a bioscaf‐
folder (SYS + ENG) were exposed to an Ar DBD plasma for 30 s, followed by immersion in a
1M 2-aminoethylmetacrylate solution and subsequent exposure to UV radiation for 60 min. In
a consecutive step, gelatin B (GelB) was immobilized on the introduced primary amines via
carbodiimide wet chemistry, and finally, those samples were immersed in a fibronectin
solution, resulting in an active physisorption of the protein (6 ng/mm²). In the initial study
published in 2012, both HFFs and MC3T3 osteoblasts were seeded on the scaffolds and the
improvements on cell colonization for each consecutive coating step (plasma treatment →
AEMA →  GelB →  fibronectin) were studied. Cross-sectional images 21 days after seeding
show that the osteoblasts only grow on the edges of the plasma-treated samples, while for all
other samples, they proliferated and migrated completely into the scaffolds (see Figure 14).
For the fibronectin rich samples, the highest density of cells was found, including the formation
of new natural ECM. In a second study, the performance of adipose-derived stem cells on
fibronectin rich scaffolds was compared to commercially available collagen hydrogel scaffolds.
Initially, the collagen scaffolds performed significantly better for seeding efficiency (×2) and
protein production (+50 %) compared to the fibronectin rich scaffolds, which can most likely
be contributed to the design of the scaffolds rather than the surface chemical properties. After
28 days, RT-PCR was performed to analyze the differentiation efficiency and selectivity.
Results show that, although there was a delay in differentiation compared to the more compact
collagen scaffolds, the fibronectin scaffolds show a better and more stimulated osteogenic
differentiation compared to the commercial collagen scaffolds. Further improvement of
scaffold designs, combined with higher concentrations of immobilized fibronectin should lead,
in our opinion, to higher seeding efficiencies and even more pronounced differentiation. Van
Bael et al. [106] repeated the exact same procedure on PCL scaffolds fabricated via selective
laser sintering (SLS) without the fibronectin physisorption and found very similar results.
Sousa et al. [107] used the BioExtruder to fabricate PCL scaffolds with pore size diameters of
900 µm. An Ar low-pressure RF plasma (100 W, 30 s) was applied and exposed to ambient air
to allow the formation of peroxides and hydroxyperoxides on the scaffold surface. This was
followed by an immersion in an acrylic acid solution combined with exposure to UV-irradia‐
tion. In a final step, collagen was immobilized onto the surface using carbodiimide wet
chemistry. M3T3 fibroblasts were seeded onto the surface, and MTT tests were performed after
7 and 14 days. Results show no significant differences toward the untreated scaffolds, but more
importantly, also no significant differences were found compared to commercially available
collagen scaffolds, unlike to what was found by other researchers. This is a strong indication
that the type of cell used for seeding (fibroblast vs osteoblast vs. stem cell) as well as the origin
of the cell (primary cell lines versus cancer cell lines) and scaffold design all play an important
role on the possible in-vitro outcome of the study.
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Nebe et al. [108] also used SLS to fabricate PLGA/tricalcium phosphate composite scaffolds
with a 500-µm pore size. An O2 low-pressure MW plasma was applied (500 W, 5 Pa, 0.1 slm,
10 s) followed by a plasma polymerization step using allylamine as a precursor (500 W, 50 Pa,
0.05 slm, 144 s), resulting in the incorporation of up to 16 % of nitrogen, as confirmed via XPS
(no mention of cross-sectional analysis). MG-63 osteoblasts were seeded onto the scaffolds,
and SEM analysis was performed in the first 30 min, showing already large differences in cell
attachment to the scaffold, yet no quantitative analysis was performed.
Owen et al. [109] and Kim et al. [110] both used an acrylic acid enriched O2 low-pressure RF
system to deposit acid rich coatings on their scaffolds with 800 and 450 µm pore diameters,
respectively. Owen et al. used the scaffolds as such, seeding human mesenchymal progenitors.
ALP activity was measured, showing that the stiffest samples combined with the acrylic acid
resulted in the best osteogenic differentiation. Kim et al. introduced an extra step, immobilizing
rhBMP-2 onto their scaffolds via simple incubation. MG-63 osteoblasts were seeded onto the
Figure 14. Viability, infiltration, and colonization on PCL and PCL GelB Fn scaffolds. Calcein AM images of HFF cells
after 1, 7, 14, and 21 days on PCL scaffolds (a–d) and PCL GelB Fn scaffolds (e–h). Colonization of the 3D scaffolds by
HFF cells 1, 7, 14, and 21 days post-seeding. Histological sections taken of the center of PCL GelB Fn scaffold [scale bar
500 lm (i–l)]. Details of the histological sections of the center of PCL GelB Fn scaffolds are given in i′–l′ (scale bar 100
lm). Hematoxylin/eosin staining of 5-lm thick paraffin sections. The pink lining is representative for the gelatin coat‐
ing. Only when cells were present, the integrity of the scaffolds could be preserved [142]
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scaffold, and again ALP activity was measured. Results show an 80 % increase of activity
compared to the coated scaffolds without immobilized protein and a 90 % increase compared
with untreated scaffolds; results that are more pronounced compared to what was found by
Owen et al.
Compared to the research performed on the plasma modification of traditionally fabricated
scaffolds, the amount of papers on plasma-modified rapid-prototyped scaffolds is more recent
and rather limited. The main reason for this is most likely the high acquisition cost of the rapid
prototyping systems, ranging somewhere between 30.000 and 250.000 euro, combined with
the fact that most of those systems can be found in biomaterials laboratories having limited
experience with plasma technology. Those groups that did perform plasma grafting/polymer‐
ization on rapid-prototyped scaffolds have found very similar results compared to results
found for modified traditional scaffolds. The main difference between the two fabrication
techniques is that there is little to no mention of possible gradients in chemistry. This suggests
that either: (1) it is not a problem thanks to the better pore interconnectivity or (2) no attention
was paid to it. The latter seems more likely, based on the results found by Jacobs et al. [71] for
a plasma-activated rapid-prototyped scaffolds. In either case, more structural studies are
required to analyze this, as well as a transfer of some of the results found for traditional
scaffolds to the rapid prototyped ones.
3.2.3. Electrospinning
Several of the experiments performed on other scaffolds have also been performed on
electrospun scaffolds; therefore, this chapter part will mainly focus on those plasma grafting
and polymerization strategies that have not been discussed for other scaffolds, while the rest
will be summarized in Table 2 [141].
Author scaffoldmaterial reactor & gas precursor cell-type effect
Shabani et al.
[118] PES
MW low
pressure
O2
collagen grafting somatic stem cells better cell infiltration into thescaffold
Jeong et al.
[119] Silk
RF low pressure
O2
CH4 polymerization
keratinocytes &
fibroblasts
addition of O2 into plasma
increases initial adhesion
Park et al.
[120] PU
MW atmospheric
plasma
Ar
PLGA grafting HUVEC
adhesion +100%
proliferation +150%
better endothelialization
Yao et al.
[121] PU
40 kHz low
pressure plasma
Ar
4-vinylpyridine
+ quaternization
S. aureus
E. coli
Log5 and Log3 reduction in
bacterial activity
Lopez-Pérez et
al. [122] PCL
RF low pressure
O2
vinyl phosphonic acid
vinyl sulfonic acid Saos-2 osteoblasts higher vitronectin adsorption
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Author scaffoldmaterial reactor & gas precursor cell-type effect
better proliferation for vinyl
phosphonic acid
Chen et al.
[123] PLLA
DC low pressure
pulsed system
O2
gelatin grafted chondrocytes
4* increase in cell viability
4* increase in collagen
production
Jia et al. [124] PCL RF low pressureAr soluble eggshell protein
human dermal
fibroblasts more elongated morphology
Park et al.
[125] PLA
RF low pressure
O2
acrylic acid
polymerization NIH 3T3
better adhesion and
proliferation + complete
coverage of the scaffold pores
within 6 days
Paletta et al.
[126] PLLA
RF low pressure
O2
cyclic RGD
grafted
mesenchymal
stem cells
no enhanced differentiation
due to limited RGD surface
densities
Seyedjafari et
al. [127] PLLA
MW low
pressure
O2
nanohydroxyapatite
grafted
unrestricted
somatic stem cells
in-vivo
Higher ALP and
mineralization + ossification
and formation of trabeculi
Santos et al.
[128]
Starch
(100µm)
RF low pressure
Ar
vitronectin & fibronectin
adsorption HUVEC
better proliferation
higher concentration
endothelial growth factors
higher cadherin activity
Ma et al.
[129] PCL
RF low pressure
air gelatin grafted endothelial cells
better morphology
aligned along fibers
Ghaedi et al.
[130] PLA
MW low
pressure
O2
collagen grafted hepatocytes efficient differentiation intoosteoblasts and adipocytes
Ai et al. [131] PHVB
MW low
pressure
O2
collagen grafted unrestrictedsomatic stem cells enhanced proliferation
Table 2. Overview of literature on plasma polymerization/grafting on ES substrates not discussed within the text.
The flexibility of nanofibers allows them to be used in a wider variety of tissue engineering
applications. An example that has been amply studied is the vascular graft. One aspect that is
critical for such applications is the haemocompatibility. Wang et al. [111] and Cheng et al. [112]
both used low-pressure RF systems to immobilize heparin on silk nanofibers and PLLA
nanofibers, respectively. Whereas Wang et al. used an Ar plasma, Cheng et al. used an
Ar/NH3 + H2 plasma. Both claim a high-grafting efficiency, however, the study of Cheng et al.
shows that their treatment strategy results in a 10-times higher adsorption rate compared to
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an Ar plasma treatment. In-vitro tests with blood platelets showed a significant decrease in
platelet attachment compared to untreated scaffolds (Cheng et al.) and a four-time longer
coagulation time (Wang et al.). Finally, the seeding of bovine aortic endothelial cells showed
an enhanced cell infiltration into the scaffold independent of the level of heparin immobilized,
suggesting that the addition of ammonia to the plasma is unnecessary (Cheng et al.). Wang et
al. tested their scaffolds in-vivo, showing excellent biocompatibility with only minor signs of
inflammation. He et al. [113] used a low-pressure ICP air plasma (30 W–5 min) to immobilize
collagen rather than heparin onto their PCL-PLLA electrospun scaffolds (470 ± 130 nm) for
vascular graft applications. Rhodamine-stained scaffolds show an excellent distribution of
collagen throughout the scaffolds. Human coronary artery endothelial cells were seeded onto
the scaffolds. The collagen-coated scaffolds stimulated the spreading, attachment, and overall
viability combined with a good preservation of the phenotype.
Another application that has received considerable attention is the fabrication of e-spun
scaffolds for nerve-guided regeneration. Delgado-Rivera et al. [114] used a plasma-patterning
technique involving a PMDS mask to generate tracks of grafted lamilin on a polyamide
nanofiber mesh. RG3.6 neural precursors were seeded onto both patterned and completely
treated scaffolds. Fluorescence microscopy showed that the precursor cells almost exclusively
stuck to the patterns growing in a bilateral fashion. Zandér et al. [115] used an air plasma
treatment (18 W–5 min) on aligned PCL nanofibers with sub-µm dimensions followed by
covalent immobilization of lamilin, using carbodiimide wet-chemistry. PC12 neuron-like
differentiated cells were seeded onto the e-spun scaffolds. SEM imaging revealed significantly
longer neurons on scaffolds that contain higher concentrations of lamilin. The authors do admit
that they have no control on how the protein is folded onto the surface, thus having no
indication on the efficiency of the immobilized lamilin, which could most likely be partially
addressed via gene expression analysis.
Guex et al. [116] focused their research on the repair of damaged myocardium using PCL fibers
coated with a CHO-type coating (ethylene + CO2) rich with ester bonds (O/C = 0.35). Mesen‐
chymal stem cells were seeded onto the scaffolds and then implanted into a rat model. Four
weeks after implantation, scaffolds were analyzed, showing that the plasma-coated grafts
significantly stabilized the cardiac function, resulted in attenuated dilation and gave cause to
lower ejection fractioning and fractional shortening all compared to untreated scaffolds.
Nuhiji et al. [117] developed a multifunctional e-spun scaffold based on the immobilization of
silane groups. Oxygen low pressure RF plasma pretreatment (63 Pa, 30 W, 3 min) resulted in
a 10-fold increase in 3-aminopropyl-trimethoxysilane or 3-mercaptopropyl-trimethoxysilane.
The silane-enriched surfaces were then immersed in a neutravidin-enriched buffer solution
overnight, resulting in the effective immobilization of the neutravidin. CD-4 antibodies were
seeded onto the scaffold, resulting in specific bonding. According to the authors, changing the
neutravidin for other biomacromolecules such as proteins, enzymes, and antibodies should be
easy, resulting in a multitool scaffold for biosensing and tissue engineering.
A wide variety of polymerizable precursors and biomacromolecules were selected by research
groups around the world to be used for plasma polymerization and plasma grafting, respec‐
tively, on electrospun scaffolds. Compared to the plasma-activated scaffolds, results were far
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more promising. In most cases, better cell proliferation rates were found on top of good initial
cell adhesion and, when applicable, cell differentiation was drastically improved. In-vivo
results were promising as well, with limited infection, good cell ingrowth, and, in a few cases,
even good vascularization. Compared to other fabrication techniques, electrospinning has
been studied quite extensively, resulting in a wider variety of possible treatment strategies.
4. Conclusion and outlook
A quite extensive overview has been given on the literature involving, in one way or the other,
the use of non-thermal plasma technology for the modification of scaffolds for tissue engi‐
neering applications. In the past 15 years, research has evolved from “simple” plasma
treatments, mostly improving cell adhesion, to quite elegant methods, often involving nothing
more than a plasma step and some protein-enriched aqueous solutions. These methods
resulted in scaffolds that were able to support cells that adhered better, proliferated better, and
differentiated better compared to their untreated counterparts. These results show that plasma
is a reliable and efficient tool that should be included in the toolbox of every tissue engineer.
Comparing the three scaffold categories reviewed here, it is to our belief that the traditionally
fabricated scaffolds will disappear over time, as the rapid prototyped scaffolds are superior in
both pore interconnectivity and biomimetic design. Electrospinning is a technique that is
complementary to the other two and should even be used in parallel with the others, combining
both structural integrity and ECM-like support structures in one scaffold design. The chal‐
lenges for the next few years will be to translate the technology from generic scaffolds to
patient-customized scaffolds that could actually be used on patients. An increase in scaffold
dimensions and complexity will be unavoidable and cause new and unexpected problems as
well as increase problems still encountered today (such as gradient depositions). Secondly,
more attention should be paid to the latest discoveries in cell biology, as this would accelerate
the tuning process of what should be immobilized on a scaffolds’ surface, thus addressing the
issue that research conducted to this day is almost exclusively unidimensional, studying the
effect of one component on cellular behavior, while it is known that most ques triggering the
cellular metabolism are multicomponent systems. Gene expression analysis is becoming more
popular, but should be systematically used to give researchers more fundamental insights into
what their surface modification techniques are triggering on a molecular level. Thirdly, at this
point, the level of in-vivo testing remains relatively low and should become more mainstream,
as literature has shown that there are often large discrepancies between results found in-vitro
and in-vivo.
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